A multi-centre, randomized, double-blind, double-dummy, multiple-dose, crossover study to evaluate the pharmacodynamics, pharmacokinetics, safety and tolerability of orally inhaled indacaterol administered as either PulmoSphere or lactose-blend powder via the Concept1 device in adult patients with persistent asthma.

Trial Profile

A multi-centre, randomized, double-blind, double-dummy, multiple-dose, crossover study to evaluate the pharmacodynamics, pharmacokinetics, safety and tolerability of orally inhaled indacaterol administered as either PulmoSphere or lactose-blend powder via the Concept1 device in adult patients with persistent asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Apr 2015

At a glance

  • Drugs Indacaterol (Primary) ; Indacaterol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2012 Actual end date (22 May 2012) added as reported by European Clinical Trials Database record.
    • 23 Jun 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 01 Dec 2011 Planned number of patients added as 36.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top